MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-18-2026
Processa Pharmaceuticals DIO Ratio 2011-2026 | PCSA
Annual DIO Ratio Processa Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | 716 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 716 | 716 | 716 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K |  USA |
 |
Alnylam Pharmaceuticals
ALNY
|
43.5 | $ 333.39 | - | $ 43.7 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
166 | $ 21.68 | - | $ 1.01 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M |  Canada |
 |
Akebia Therapeutics
AKBA
|
147 | $ 1.55 | - | $ 399 M | USA |
 |
Aquestive Therapeutics
AQST
|
120 | $ 4.24 | - | $ 453 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
185 | $ 24.58 | - | $ 3.13 B | USA |
 |
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.49 | - | $ 397 M | Britain |
 |
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Caladrius Biosciences
CLBS
|
35.8 | - | -16.75 % | $ 25.8 M | USA |